The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients

The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients

BackgroundJAK inhibitors treat various autoimmune diseases, but an updated systematic review in treating alopecia areata is currently lacking.ObjectiveEvaluate the specific efficacy and safety of JAK inhibitors in alopecia areata by systematic review and meta-analysis.MethodsEligible studies in PubM...

Full description

Bibliographic Details
Main Authors:	Mei-qi Mao, Yu-xin Ding, Jing Jing, Zhen-wei Tang, Yu-jie Miao, Xiao-shuang Yang, Yu-hong Chen, Sheng-zhao Chen, Xian-jie Wu, Zhong-fa Lu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-06-01
Series:	Frontiers in Immunology
Subjects:	JAK/STAT (janus kinase/signal transducer and activator of transcription) JAK inhibitors alopecia areata immune-mediated diseases meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1195858/full

Similar Items

Sisaipho alopecia areata treated with tofacitinib and oral minoxidil
by: Ronan Talty, BS, et al.
Published: (2022-11-01)

Inhibidores de JAK: usos en dermatología. Parte 1: generalidades, aplicaciones en vitíligo y en alopecia areata
by: C. Garcia-Melendo, et al.
Published: (2021-06-01)

An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
by: Maddison Lensing, et al.
Published: (2022-08-01)

Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
by: He X, et al.
Published: (2024-03-01)

The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
by: Diqin Yan, et al.
Published: (2022-08-01)

At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
by: Katerina Yale, MD, et al.
Published: (2020-05-01)

Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib—A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata
by: Kinga Kołcz, et al.
Published: (2023-01-01)

Insights, current status and future perspective of JAK inhibitors in the treatment of alopecia areata
by: Xingqi ZHANG
Published: (2022-04-01)

Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date
by: Sofia Faria, et al.
Published: (2023-09-01)

Efficacy and safety of JAK inhibitors in the treatment of alopecia areata in children: a systematic review and meta-analysis
by: Yi Chen, et al.
Published: (2022-11-01)

A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
by: Dillon KAL
Published: (2021-06-01)

Clinical response to oral tofacitinib in pediatric patients with alopecia areata
by: Soundos Youssef, MD, et al.
Published: (2023-01-01)

Is the JAK-STAT Signaling Pathway Involved in the Pathogenesis of Depression?
by: Małgorzata Gałecka, et al.
Published: (2022-04-01)

Survey of pediatric dermatologist views on treatment for alopecia areata
by: David Bitterman, BA, et al.
Published: (2023-12-01)

Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
by: Ana M. Montilla, et al.
Published: (2019-10-01)

Gut instinct: Using tofacitinib to treat alopecia areata in the context of comorbid inflammatory bowel disease
by: Danielle M. Peterson, MD, et al.
Published: (2021-01-01)

Effective treatment of alopecia universalis with oral upadacitinib
by: Soundos Youssef, MD, et al.
Published: (2023-01-01)

Transient Efficacy of Tofacitinib in Alopecia Areata Universalis
by: Florian Anzengruber, et al.
Published: (2016-04-01)

Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
by: Kabir Sardana, et al.
Published: (2023-01-01)

Alopecia areata: Update on management
by: Julie S Kranseler, et al.
Published: (2017-01-01)

Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series
by: Leah Alexandra Johnston, BSc, MD, et al.
Published: (2023-05-01)

JAK–STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review
by: I-Hsin Huang, et al.
Published: (2022-12-01)

Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
by: Dongfan Wei, et al.
Published: (2023-04-01)

Case Report: A Case of Myeloproliferative Neoplasm Complicated by Alopecia Areata
by: Yotaro Tamai, et al.
Published: (2022-05-01)

Drug Survival and Long-term Outcome of Tofacitinib in Patients with Alopecia Areata: A Retrospective Study
by: Jundong Huang, et al.
Published: (2023-11-01)

Tratamento adjuvante com minoxidil oral para tratamento de alopecia areata refratária a inibidores de JAK
by: Carlos Gustavo Wambier, et al.
Published: (2020-01-01)

The Role of JAK/STAT Pathway in Fibrotic Diseases: Molecular and Cellular Mechanisms
by: Jia Liu, et al.
Published: (2023-01-01)

Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
by: Olivia Katamanin, BS, et al.
Published: (2024-01-01)

Baricitinib Therapy for Moderate to Severe Alopecia Areata: A Retrospective Review of 95 Japanese Patients
by: Takafumi Numata, et al.
Published: (2024-01-01)

Gut microbiome, metabolome and alopecia areata
by: Zhiyu Liu, et al.
Published: (2023-11-01)

Characteristics and Outcomes of Patients on Tofacitinib for Alopecia Areata or Rheumatoid Arthritis: A Retrospective Cohort Study
by: Sarah Choe, et al.
Published: (2024-01-01)

Alopecia areata: from pathophysiology to therapeutic innovation
by: Nuno Lourenço, et al.
Published: (2023-04-01)

Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
by: Jundong Huang, et al.
Published: (2023-10-01)

Inhibition of T-cell activity in alopecia areata: recent developments and new directions
by: Thierry Passeron, et al.
Published: (2023-11-01)

Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
by: Alexander Egeberg, et al.
Published: (2023-10-01)

Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
by: Ting Yan, et al.
Published: (2024-04-01)

Nail involvement in patients with moderate-to-severe alopecia areata treated with oral tofacitinib
by: Ji Su Lee, et al.
Published: (2018-11-01)

Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
by: Farnam Barati Sedeh, et al.
Published: (2023-01-01)

“Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
by: Emira Bousoik, et al.
Published: (2018-07-01)

Phytochemicals Targeting JAK–STAT Pathways in Inflammatory Bowel Disease: Insights from Animal Models
by: Sun Young Moon, et al.
Published: (2021-05-01)